Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 10561 - 10568 of 12007 results

IRS Issues More Guidance on 457(b) Plan Corrections

March 19, 2014| Blog| Viewpoint

Working (More Than) 9-to-5: President Obama Seeks to Expand Overtime Pay Protections Under the Fair Labor Standards Act

March 19, 2014| Blog| Viewpoint

Unauthorized Children’s In-App Purchases Round Two: Google Faces Class Action

March 19, 2014| Blog| Viewpoint

Bracketology 101: Part I – The Bracket: A Look Ahead at Legal Issues that May Change the Face of the Final Four

March 18, 2014| Blog| Viewpoint

For New Recovery Audit Contracting Cycle, CMS “RAC”s up Changes

March 18, 2014| Blog| Viewpoint

Over 20 Million Customer Accounts Affected by Data Breaches in California; Attorney General Harris Promises Increased Enforcement

March 18, 2014| Blog| Viewpoint

Forward-Publishing Patents: A Way to Tell Competitors "Stay Out"?

March 17, 2014| Blog| Viewpoint

The Affordable Care Act—Countdown to Compliance for Employers, Week 41: What Employers Need to Know About the Final Rules Issued by the Department of Health and Human Services Relating to Transitional Reinsurance Fees, Public Exchanges, Etc.

March 17, 2014| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases